Evaluation of the Results of Intralesional Bleomycin Injection for Treatment of Haemangioma and Vascular Malformation Atta Ahmed T.1, Elbasiouny Mahmoud S.2, Nada Ahmed Hosny3,*, Ali Rama Ahmed4, Alkonaiesy Fady M.5 1Professor of Plastic Surgery, Faculty of Medicine, Cairo University, Egypt 2Professor of General Surgery, National Laser Institute, Cairo University, Egypt 3Specialist of Plastic Surgery, Department of Plastic Surgery, Matariateaching Hospital, Cairo, Egypt 4Asissatant Professor of Plastic Surgery, Faculty of Medicine, Cairo University, Egypt 5Specialistof Plastic Surgery, Nasser Institute Hospital, Cairo, Egypt *Corresponding author: Ahmed Hosny Nada, Specialist of Plastic Surgery, Department of Plastic Surgery, Mataria teaching Hospital, Cairo, Egypt, E-mail: drahmdnada@gmail.com
Online published on 31 March, 2020. Abstract Aim Is to evaluate the results of intralesional bleomycin injection for treatment of haemangiomaand vascular malformation. Indications, limitations, adjustment of dose and results of treatment Patients and Method This study was carried out on 40 patients with vascular anomalies; either hemangioma or vascular malformations from both sexes at different age groups. Patients treated with intralesional Bleomycin Injection and treatment response will be evaluated Results 26 cases (65%) present significant response which includes complete resolution, excellent and good response; 7 cases (17.5%) presents fair response and 7 cases (17.5%) presents poor response. No cases presents no change or increase in size Conclusion Intralesional bleomycin injection (IBI) is a simple, practical and noninvasive method of treatment of vascular anomalies and can considered one of priorities in the treatment of Infantile Hemangiomas and small and medium sized venous malformations. Top Keywords Vascular anomalies, Infantile Hemangioma (IH), vascular malformation, Bleomycin and Intralesional Bleomycin Injection (IBI). Top |